Philips launches new cardiograph with rapid diagnosis
28 August 2009
Royal Philips Electronics (AEX: PHI, NYSE: PHG) is to unveil its
latest advance in cardiography, the PageWriter TC50 cardiograph, at the
European Society of Cardiology (ESC) Congress 2009 (Barcelona, 29 Aug-2
Sept). On show for the first time, the PageWriter TC50 offers an
intuitive operation and advanced clinical decision support.
The PageWriter TC50 aims to help clinicians meet demands and shift
the focus to patients. Its ability to handle up to 16 leads provides a
more complete view of the heart, and its anatomically designed patient
interface module makes attaching lead wires quick and intuitive,
contributing to timely triage.
As heart disease manifests itself in different patients in different
ways, physicians always face the challenge to quickly and accurately
diagnose heart attacks. For this reason, Philips has packed the
PageWriter TC50 with a variety of tools to aid clinicians with this
task, including those enabled by the innovative DXL 16-lead ECG
The DXL Algorithm’s ST Maps provide a graphical representation of ST
elevation in patients, a key measure in the diagnosis of ischemia.
STEMI-CA can identify which coronary artery is blocked, aiding the
clinician in planning the appropriate intervention.
In addition, since heart disease in women often occurs in smaller
vessels with less obstruction and more subtle symptoms, the ECG analysis
programme used by the PageWriterTC50 uses gender-differentiated criteria
to help interpret cardiac symptoms in women, including the
identification of acute global ischemia.
“We have developed this product as part of Philips’ ongoing efforts
to simplify cardiac care now and in the future,” commented Joris van den
Hurk, vice president of cardiology programs for Philips Healthcare.
“The PageWriter TC50 and the DXL Algorithm help clinicians in their
decision-making by presenting the right information with clarity at the
right time. As one product in our innovative Discovery to Treatment
portfolio, the PageWriter TC50 supports healthcare facilities in their
goal of meeting the ESC’s guideline of less than two hours from first
medical contact to treatment.”
Bookmark this page